What happened: The US and UK are expected to finalise a deal to eliminate tariffs on branded drug imports. This follows previous threats of tariffs up to 100% on these products.
Why it matters:
- It will reduce costs for pharmaceutical companies and potentially lower drug prices.
- Patients and healthcare systems in both countries could benefit from improved access to medicines.
MNN Take: By removing tariffs on pharmaceuticals, the US and UK aim to support trade and healthcare sectors, ensuring smoother supply of essential medicines.
Sources: BBC US & Canada